CAS: 103733-65-9; (R)-1,2,3,4-Tetrahydro-3-Isoquinolinecarboxylic Acid

该化合物是一种手性化合物,其特征是四氢索松碱结构,由氮原子的双环系统组成,该化合物因其碳箱酸功能组而显著,有助于其酸度和潜在的再活性;由于有手性中心的存在,因此可以存在对应剂,使其在医药领域具有重要性,在药品领域,立体化学可以影响生物活动;经常研究其在药用化学领域的潜在应用,特别是在针对...

结构式图片

相似化合物

74163-81-8 67123-97-1 115962-35-1

欧盟法规

ECHA物质C&L通报

上下游产品

CAS号50-00-0 甲醛 | CAS号673-06-3 D-苯丙氨酸 | CAS号146503-35-7 (3r)-1,2,3,4-四氢... | CAS号612-12-4 邻二氯苄 | CAS号143767-55-9 2-乙酰基-1,2-二氢异喹啉... | CAS号91-13-4 α,α'-二溴邻二甲苯 | CAS号67123-97-1 1,2,3,4-四氢异喹啉-3-羧酸 | CAS号143767-54-8 2-乙酰基-1,2,3,4-四... | CAS号146503-35-7 (3r)-1,2,3,4-四氢... | CAS号191327-28-3 (R)-1,2,3,4-四氢异...

合成工艺路线路线简述

  • 合成目标产物 D-1,2,3,4-Tetrahydroisoquinoline-3-Carboxylic Acid 主要起始原料 N-(Diphenylmethylene)Glycerine Tert-Butyl Ester And 1,2-Bis(Bromomethyl)Benzene
  • (文献来源)合成步骤主要原料 N-(Diphenylmethylene)Glycerine Tert-Butyl Ester 和 1,2-Bis(Bromomethyl)Benzene
Benzyl (3R)-Methyl-1,2,3,4-Tetrahydroisoquinoline-3-Carboxylate置于sodium Hydroxide体系中,用 水 用作溶剂,化学反应 15.0H,以90%的收率获得(R)-(+)-1,2,3,4-四氢异喹啉-3-羧酸
参考文献:Efficient Synthesis Of Racemic And Enantiomerically Pure 1,2,3,4-Tetrahydroisoquinoline-3-Carboxylic Acid And Esters
标题:Efficient Synthesis Of Racemic And Enantiomerically Pure 1,2,3,4-Tetrahydroisoquinoline-3-Carboxylic Acid And Esters
摘要:在碱催化下,1,2-双(卤甲基)苯 1 A 或 B 与 2-(乙酰氨基)丙二酸二乙酯(2)发生环化反应,随后发生脱羧反应和酰胺裂解反应,制备出了外消旋和光学纯的 1,2,3,4-四氢异喹啉-3-羧酸及酯.对映体的分解是通过与(-)-薄荷醇酯化,然后柱层析分离非对映异构体混合物,或通过与扁桃酸分离苄酯的双酯盐,以及碱催化两种酯的皂化反应来实现的.
Doi:10.1055/s-1992-26325

海关参考信息

专利信息


专利号:US-2023391818-A1
优先权日:2020-11-05
标 题:Peptide synthesis method for suppressing defect caused by diketopiperazine formation
发明人:NOMURA KENICHI; KAGE MIRAI; TAMIYA MINORU; KANAZAWA JUNICHIRO
权利人:CHUGAI PHARMACEUTICAL CO LTD
摘要:Solid-phase synthesis of a peptide has a problem that a desired elongation reaction is prevented from proceeding by diketopiperazine and a 6-membered diamine skeleton compound formed when a protective group at the N-terminal is removed. The present inventors have found that when in production of a peptide by a solid-phase method, a peptide in which an amino group at the N-terminal is protected with a protective group having an Fmoc skeleton is treated in a specific solvent with a base having a pKa of 23 or more in acetonitrile as a conjugate acid, and a peptide chain is then elongated, it is possible to solve the problem described above.

专利号:US-5587481-A
优先权日:1996-02-20
标 题:Preparation of (S)-decahydroisoquinoline-3-carboxylic acid t-butylamide
发明人:ALLEN DAVID R; JENKINS SCOTT; KLEIN LORAINE; ERICKSON ROBERT; FROEN DIANE
权利人:MONSANTO CO
摘要:Methods for preparing (S)-N-tert-butyl-1,2,3,4-tetrahydro-3-isoquinoline-carboxamide ('tic-c'), and converting tic-c to (S)-decahydroisoquinoline-3-carboxylic acid t-butylamide ('tic-d') are disclosed. The initial step in the formation of tic-c involves the phosgenation of a substituted tetrahydroisoquinoline to form an N-carboxy anhydride. Tic-d is used as an intermediate in the synthesis of known compounds having pharmaceutical activity.

专利号:US-11420997-B2
优先权日:2018-04-13
标题:Peptide synthesis method
发明人:SUZUKI HIDEAKI; MUTO SUSUMU; FUJITA SHUJI; KUBO DAISUKE
权利人:JITSUBO CO LTD
摘要:The present invention has an object of shortening the process time and reducing use of a poor solvent for solidifying a carrier (Tag)-peptide component, by removing impurities without conducting solid-liquid separation (condensation, solid-liquid separation and drying operation) of a Tag-peptide component, in an Fmoc method using a Tag for liquid phase peptide synthesis. Provided is the peptide synthesis method that includes the following steps a-d: step a: a carrier-protected amino acid, carrier-protected peptide, or a carrier-protected amino acid amide, and an N-Fmoc-protected amino acid or an N-Fmoc-protected peptide are condensed in an organic solvent or a mixed solution of organic solvents, to obtain an N-Fmoc-carrier-protected peptide, step b: a water-soluble amine is added to the reaction solution after the condensation reaction, step c: the Fmoc group is deprotected from the protected amino group in the presence of a water-soluble amine, and step d: the reaction solution is neutralized by adding an acid, and further, by adding and washing with an acidic aqueous solution, then, by liquid-liquid separation an aqueous layer is removed to obtain an organic layer.

专利号:WO-2023214577-A1
优先权日:2022-05-02
标 题 :Peptide synthesis method for suppressing defect caused by diketopiperazine formation
发明人:KAGE MIRAI; TAMIYA MINORU; KANAZAWA JUNICHIRO; NOMURA KENICHI
权利人:CHUGAI PHARMACEUTICAL CO LTD
摘要:The present invention addresses the problem of a desired elongation reaction not progressing as a result of a 6-membered cyclic amidine skeleton structure and a diketopiperazine formed when removing an N-terminated protective group during peptide synthesis. The inventors have discovered that it is possible to solve said problem during peptide production by treating a peptide protected by an N-terminated amino group in a protective group having an Fmoc skeleton by using a base which has a pKa of 23 or higher in an acetonitrile of a conjugate acid in a specific solvent, and next, performing peptide chain elongation.

专利号:CN-110776558-B
优先权日:2019-07-01
标 题:A kind of method of solid phase synthesis icatibant acetate
上海创拓生物科技有限公司
⚠️ 未注册 · 未认证企业
⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
数据来源于公开网络搜索,平台未作核实,请自行辨别。
🏢敬请 企业认领
🏬开设公司展台
📢获取免费会员权益
🎖️点亮专属注册企业标签
📇展现公司完整信息 样本查看立即注册认领 →
网址: http://www.chuangtuobio.com
电话: 021-64301660 18121244935👤
📞上海创拓生物科技有限公司 ⚠️参考联系方式

销售电话:021-64301660 18121244935
邮箱:sales@chuangtuobio.com
🆔 联系时候可告知是从"百琢研"平台获取的信息.
⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

地址:金山区学府路1379弄100号
⚠️ 未注册 · 未认证企业
注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别 ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
第 1 / 1 页
现货

供应商参考报价(招募中)

品牌试剂参考报价(招募中)

📌 第三方产品分析报告

✅ COA系统入驻 | 共享模式

主要参考文献

[参考文献]: Valle G, Et Al. Constrained Phenylalanine Analogues. Preferred Conformation Of The 1,2,3,4-Tetrahydroisoquinoline-3-Carboxylic Acid (Tic) Residue. Int J Pept Protein Res. 1992 Sep-Oct;40(3-4):222-32.
[参考文献]: G Valle, Et Al. Constrained Phenylalanine Analogues. Preferred Conformation Of The 1,2,3,4-Tetrahydroisoquinoline-3-Carboxylic Acid (Tic) Residue. Int J Pept Protein Res. 1992 Sep-Oct;40(3-4):222-32.

合成参考文献


参考文献:10.1124/mol.119.115964
摘要:Lee TD, Lee OW, Brimacombe KR, Chen L, Guha R, Lusvarghi S, Tebase BG, Klumpp-Thomas C, Robey RW, Ambudkar SV, Shen M, Gottesman MM, Hall MD. A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein. Molecular Pharmacology. 2019 Nov;96(5):629–40. doi: 10.1124/mol.119.115964.
参考文献:10.1093/chromsci/43.3.121
摘要:Quan Z, Song Y, Saulsberry A, Sheng Y, Liu Y-. Capillary Electrophoresis for Diastereomers of (R,S)-Tetrahydroisoquinoline-3-Carboxylic Acid Derivatized with (R)-4-Nitro-7-(3-Aminopyrrolidin-1-yl)-2,1,3-Benzoxadiazole: Effect of Molecular Geometries. Journal of Chromatographic Science. 2005 Mar 01;43(3):121–5. doi: 10.1093/chromsci/43.3.121.
📝 需求与反馈
尽可能描述清楚需求与问题信息
×

通知